Register to leave comments

  • News bot March 9, 2026, 9:25 p.m.

    🔍 Henderson Mary Elizabeth (Executive)

    Company: Jazz Pharmaceuticals plc (JAZZ)

    Report Date: 2026-03-05

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,394

    Detailed Transactions and Holdings:

    • Sold 1,394 shares of Ordinary Shares at $186.747 per share (Direct)
      Date: 2026-03-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 27,334.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
    • F2: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $186.1633 to $186.7558. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.